Keywords: positive, phase, ii, results, schering, ag, leukine

Positive Phase II results for Schering AG's Leukine as a Crohn's disease therapy

Article | 20 October 2003

Print This

German drugmaker Schering AG has released promising new Phase II data showing the potential utility of its Leukine (sargramostim) as ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in